Target Name: ZC3H14
NCBI ID: G79882
Review Report on ZC3H14 Target / Biomarker Content of Review Report on ZC3H14 Target / Biomarker
ZC3H14
Other Name(s): Zinc finger CCCH-type containing 14, transcript variant 3 | Renal carcinoma antigen NY-REN-37 | MGC26892 | Zinc finger CCCH-type containing 14, transcript variant 1 | mammalian suppressor of tau pathology-2 | FLJ11806 | ZC3H14 variant 1 | NY-REN-37 | Nuclear protein UKp68 | MRT56 | SUT2 | zinc finger CCCH-type containing 14 | renal carcinoma antigen NY-REN-37 | Zinc finger CCCH domain-containing protein 14 | MSUT-2 | Zinc finger CCCH domain-containing protein 14 (isoform 1) | Mammalian suppressor of tau pathology-2 | ZC3HE_HUMAN | UKp68 | nuclear protein UKp68 | Zinc finger CCCH domain-containing protein 14 (isoform 3) | ZC3H14 variant 3 | MSUT2

Zinc Finger Gene and Cancer Research

Zinc finger CCCH-type containing 14 (ZC3H14) is a protein that is expressed in various tissues and organs, including brain, heart, liver, and muscle. It is a type of zinc finger gene that is characterized by the presence of a zinc finger domain and a CCCH-type repeat sequence. ZC3H14 is a transcript variant that has been identified in various organisms, including humans.

The zinc finger gene is a family of transmembrane proteins that are characterized by the presence of a zinc finger domain. This domain is a common structural feature that is found in many proteins that play important roles in cellular signaling. Zinc fingers are involved in the regulation of gene expression by binding to specific DNA sequences. They are also known as nuclear-remodeling proteins because they are able to alter the structure of the chromatin DNA.

ZC3H14 is a specific type of zinc finger gene that is characterized by the presence of a CCCH-type repeat sequence. This repeat sequence is a common structural feature that is found in many proteins that are involved in signaling pathways. CCCH-type repeat sequences are composed of a specific sequence of amino acids that is repeated multiple times. They are often involved in the regulation of protein function and are often used as drug targets.

The ZC3H14 protein is a transcript variant that has been identified in various organisms, including humans. It is expressed in various tissues and organs, including brain, heart, liver, and muscle. ZC3H14 is involved in the regulation of cellular processes, including cell signaling , DNA replication, and gene expression. It is also involved in the development and progression of various diseases, including cancer.

In terms of its potential as a drug target, ZC3H14 is an attractive target for research because of its involvement in the regulation of cellular processes that are associated with various diseases. For example, ZC3H14 has been shown to be involved in the regulation of cell signaling pathways that are associated with cancer. It is also involved in the regulation of DNA replication, which is a critical process that is involved in the development and progression of cancer.

In addition to its potential as a drug target, ZC3H14 is also a valuable biomarker for the diagnosis and treatment of various diseases. For example, it has been shown to be involved in the regulation of cellular processes that are associated with aging, including the regulation of DNA replication and gene expression. It is also involved in the development and progression of various neurological and psychiatric diseases, including Alzheimer's disease and depression.

Overall, ZC3H14 is a protein that is worthy of further investigation as a potential drug target and biomarker. Its structure and function continue to be investigated to better understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: Zinc Finger CCCH-type Containing 14

Functions: Involved in poly(A) tail length control in neuronal cells. Binds the polyadenosine RNA oligonucleotides

The "ZC3H14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZC3H14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZC3H15 | ZC3H18 | ZC3H18-AS1 | ZC3H3 | ZC3H4 | ZC3H6 | ZC3H7A | ZC3H7B | ZC3H8 | ZC3HAV1 | ZC3HAV1L | ZC3HC1 | ZC4H2 | ZCCHC10 | ZCCHC12 | ZCCHC13 | ZCCHC14 | ZCCHC14-DT | ZCCHC17 | ZCCHC18 | ZCCHC2 | ZCCHC24 | ZCCHC3 | ZCCHC4 | ZCCHC7 | ZCCHC8 | ZCCHC9 | ZCRB1 | ZCWPW1 | ZCWPW2 | ZDBF2 | ZDHHC1 | ZDHHC11 | ZDHHC11B | ZDHHC12 | ZDHHC12-DT | ZDHHC13 | ZDHHC14 | ZDHHC15 | ZDHHC16 | ZDHHC17 | ZDHHC18 | ZDHHC19 | ZDHHC2 | ZDHHC20 | ZDHHC20P1 | ZDHHC20P2 | ZDHHC21 | ZDHHC22 | ZDHHC23 | ZDHHC24 | ZDHHC3 | ZDHHC4 | ZDHHC5 | ZDHHC6 | ZDHHC7 | ZDHHC8 | ZDHHC8BP | ZDHHC9 | ZEB1 | ZEB1-AS1 | ZEB2 | ZEB2-AS1 | ZER1 | ZFAND1 | ZFAND2A | ZFAND2B | ZFAND3 | ZFAND4 | ZFAND5 | ZFAND6 | ZFAS1 | ZFAT | ZFAT-AS1 | ZFC3H1 | ZFHX2 | ZFHX3 | ZFHX4 | ZFHX4-AS1 | ZFP1 | ZFP14 | ZFP2 | ZFP28 | ZFP28-DT | ZFP3 | ZFP30 | ZFP36 | ZFP36L1 | ZFP36L2 | ZFP37 | ZFP41 | ZFP42 | ZFP57 | ZFP62 | ZFP64 | ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90